Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
768,291
-
Share change
-
+116,091
-
Total reported value
-
$11,104,308
-
Price per share
-
$14.45
-
Number of holders
-
22
-
Value change
-
+$1,097,964
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q4 2018
As of 31 Dec 2018,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
768,291 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Vanguard Group Inc, Granite Point Capital Management, L.P., ESSEX INVESTMENT MANAGEMENT CO LLC, NORTHERN TRUST CORP, UBS OCONNOR LLC, PRELUDE CAPITAL MANAGEMENT, LLC, BRASADA CAPITAL MANAGEMENT, LP, Eversept Partners, LP, and Spark Investment Management LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.